Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-048199

Chairman and CEO bought 250 shares at $1.59 ($398)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-08-21 Purchase +250 $1.59 $398 10,678,246 D
Open-market purchases · 250 sh · avg $1.59 · $398
Loading xslF345X03/doc4.xml…